SCHEMBL19617537

SCHEMBL19617537

CC1(C)CN(C(=O)O)CCC1O

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 5/20 0.33
ACHE P22303 1/20 0.33
NPC1 O15118 1/20 0.33
KMT2A Q03164 3/20 0.31
GAA P10253 2/20 0.31
MEN1 O00255 2/20 0.31
RECQL P46063 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
EPHX2 P34913 1/20 0.31
ATM Q13315 1/20 0.31
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27970472 1.00 SMN1; SMN2 (0.35) SMN1; SMN2ALDH1A1ACHENPC1KMT2A
SCHEMBL23578669 0.82 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1NPC1KMT2AGAA
SCHEMBL30782492 0.81 SMN1; SMN2 (0.33) SMN1; SMN2ALDH1A1NPC1L3MBTL1
SCHEMBL17438862 0.81 SMN1; SMN2 (0.33) SMN1; SMN2ALDH1A1NPC1EPHX2
SCHEMBL28087458 0.81 SMN1; SMN2 (0.33) SMN1; SMN2ALDH1A1NPC1L3MBTL1
SCHEMBL20973539 0.81 SMN1; SMN2 (0.33) SMN1; SMN2ALDH1A1NPC1EPHX2
SCHEMBL14434440 0.79 ALDH1A1 (0.52) ALDH1A1EPHX2
SCHEMBL4246046 0.79 SMN1; SMN2 (0.38) SMN1; SMN2GAAL3MBTL1
SCHEMBL12491777 0.79 SMN1; SMN2 (0.38) SMN1; SMN2GAAL3MBTL1
SCHEMBL4695720 0.78 SMN1; SMN2 (0.31) SMN1; SMN2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023243601-A1 AZACYCLOALKYL CARBONYL CYCLIC AMINE COMPOUND モジュラス株式会社 2023-12-21 WO disclosed
EP-3458449-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS Xenon Pharmaceuticals Inc. (CA) 2019-03-27 EP disclosed
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO disclosed